Status:
COMPLETED
Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care
Lead Sponsor:
Tan Tock Seng Hospital
Collaborating Sponsors:
Nanyang Technological University
Woodlands Health Campus
Conditions:
Enteral and Supplement Feeds Adverse Reaction
Gastrointestinal Diseases
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
This is a trial on the feasibility of magnetic tracking for the confirmation of nasogastric tube location in human patients.
Detailed Description
In order to address the clinical need for the localization of nasogastric tube (NGT) at point-of-care, Nanyang Technological University, Tan Tock Seng Hospital and Woodlands Health Campus co-developed...
Eligibility Criteria
Inclusion
- \- Patients from the general ward or the Otorhinolaryngology clinic of Tan Tock Seng Hospital who had an NGT inserted within the last 10 days and chest X-ray confirming its correct placement
- The NGT inserted is a Ryles tube size Fr 14 or 16
- COVID negative or not deemed to be infective as judged by the prevailing policies at the time of recruitment
- Age \> or = 21 years
- BMI \< 35
- Height \< 1.9m
- Mentally competent for informed consent
Exclusion
- • Radiological:
- On chest X-ray, the length of the NGT distal to the gastroesophageal junction is less than 12cm, or the side-holes of the NGT can be visualized in the esophagus.
- The NGT is kinked within 10cm of its tip
- The chest X-ray is rotated such that the thorax is not oriented in the frontal plane
- The NGT cannot be visualized in the mediastinum
- The second intercostal space cannot be visualized on chest X-ray
- • Medically unstable:
- Heart rate \>=100 or \<60
- Systolic blood pressure \>=160 or \<100
- SpO2 \<92% in patients with chronic lung disease and \<95% in patients without chronic lung disease
- Temperature \>= 38 degrees Celsius
- • Chest wall deformity:
- Patients with pectus carinatum or excavatum, defined by physical examination
- • Patients with the following implants
- Pacemaker
- Automatic cardioverter defibrillator
- Ferromagnetic coronary stents or heart valves
- Ferromagnetic implants of the cranium, face, spine, sternum or ribs
- Ferromagnetic surgical clips or implants in the head, neck, thorax, abdomen or pelvis
- • Following conditions within the last 30 days
- Upper gastrointestinal bleeding
- Oesophageal or gastric surgery
- Stroke
- Myocardial infarction
- Aortic dissection
- Ruptured aortic aneurysm
- Allergy to neodymium, gold, epoxy or nitinol
- Not able to understand English, Chinese, Malay or Tamil
- Women whose last menstrual period commenced more than 4 weeks before recruitment unless they have a negative urinary or serum pregnancy test during their current admission.
Key Trial Info
Start Date :
May 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05204901
Start Date
May 4 2022
End Date
December 7 2022
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tan Tock Seng Hospital
Singapore, Singapore, 308433